Event JSON
{
"id": "c96609de55fedb544d801a6d68dc99b493d96d497e30a655cbbff469bbf1daeb",
"pubkey": "b8f79cff66b2e593b08a5eba662e9dcbf3b626d5652e61b3b8cd8950a7733a38",
"created_at": 1734603996,
"kind": 1,
"tags": [
[
"r",
"https://finance.yahoo.com/news/330-jobs-hit-novartis-closes-102052730.html"
],
[
"subject",
"Some 330 jobs hit as Novartis closes Morphosys, WiWo reports"
],
[
"published_at",
"1734603652"
],
[
"image",
"https://media.zenfs.com/en/reuters-finance.com/183089e9d4e436d654c89e32f028159c"
],
[
"p",
"b8f79cff66b2e593b08a5eba662e9dcbf3b626d5652e61b3b8cd8950a7733a38",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://media.zenfs.com/en/reuters-finance.com/183089e9d4e436d654c89e32f028159c"
],
[
"t",
"Technology:perspective"
],
[
"summary",
"Novartis has decided to close down Morphosys, a German biotech company it acquired in November 2024, by the end of 2025. The decision will affect 330 jobs. Novartis will integrate Morphosys' portfolio activities into its own operations."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqhrmeelmxktje8vy2t6axvt5ae0emvfk4v5hxrvaceky4pfmn8guq4j834n\nhttps://media.zenfs.com/en/reuters-finance.com/183089e9d4e436d654c89e32f028159c\n\nhttps://finance.yahoo.com/news/330-jobs-hit-novartis-closes-102052730.html",
"sig": "a88f1ef9aa49d340d744399358679e1f453223e33f97874d126e86f38020e6bf7fa449e030cf065be72c55ece2cc9181c09ec65984cf9df1569a830bff9e03c6"
}